Chondroitinase injection improves keloid pathology by reorganizing the extracellular matrix with regenerated elastic fibers

Journal of Dermatology

Volumn 40, Issue 5, 2013, Pages 380-383

  Ishiko, Toshihiro ^a   Naitoh, Motoko ^a   Kubota, Hiroshi ^b   Yamawaki, Satoko ^a   Ikeda, Mika ^a   Yoshikawa, Katsuhiro ^a   Fujita, Hiroshi ^c   Yamaguchi, Hiroaki ^c   Kurahashi, Yasuhiro ^c   Suzuki, Shigehiko ^a  

^a KYOTO UNIVERSITY   (Japan)

^b AKITA UNIVERSITY   (Japan)

^c SEIKAGAKU CORPORATION   (Japan)

Author keywords

chondroitinase ABC; elastic fibers; glycosaminoglycan; keloids; wound healing

Indexed keywords

CHONDROITIN ABC LYASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DRUG MECHANISM; ELASTIC FIBER; EXTRACELLULAR MATRIX; HUMAN; HUMAN TISSUE; KELOID; MOUSE; NONHUMAN; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; ANIMALS; CHONDROITIN ABC LYASE; DRUG EVALUATION, PRECLINICAL; ELASTIC TISSUE; EXTRACELLULAR MATRIX; FEMALE; HUMANS; INJECTIONS, INTRALESIONAL; KELOID; MALE; MICE, INBRED BALB C; MICE, NUDE; REGENERATION;

EID: 84877777506     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/1346-8138.12116     Document Type: Article

References (21)

1. Heenan PJ,. Tumors of the Fibrous Tissue Involving the Skin. In:, Elder D, ed. Lever's Histopathology of the Skin, 8th edn. Philadelphia: Lippincott-Raven Publishers, 1997; 847-887.
2. Naitoh M, Kubota H, Ikeda M, et al,. Gene expression in human keloids is altered from dermal to chondrocytic and osteogenic lineage. Genes Cells 2005; 10: 1081-1091.
3. Peltonen J, Hsiao LL, Jaakkola S, et al,. Activation of collagen gene expression in keloids: co-localization of type I and VI collagen and transforming growth factor-beta 1 mRNA. J Invest Dermatol 1991; 97: 240-248.
4. Naitoh M, Hosokawa N, Kubota H, et al,. Upregulation of HSP47 and collagen type III in the dermal fibrotic disease, keloid. Biochem Biophys Res Commun 2001; 280: 1316-1322.
5. Bhangoo KS, Quinlivan JK, Connelly JR,. Elastin fibers in scar tissue. Plast Reconstr Surg 1976; 57: 308-313.
6. Kamath NV, Ormsby A, Bergfeld WF, House NS,. A light microscopic and immunohistochemical evaluation of scars. J Cutan Pathol 2002; 29: 27-32.
7. Ikeda M, Naitoh M, Kubota H, et al,. Elastic fiber assembly is disrupted by excessive accumulation of chondroitin sulfate in the human dermal fibrotic disease, keloid. Biochem Biophys Res Commun 2009; 390: 1221-1228.
8. Rosenbloom J, Abrams WR, Mecham R,. Extracellular matrix 4: the elastic fiber. FASEB J 1993; 7: 1208-1218.
9. Hirai M, Ohbayashi T, Horiguchi M, et al,. Fibulin-5/DANCE has an elastogenic organizer activity that is abrogated by proteolytic cleavage in vivo. J Cell Biol 2007; 176: 1061-1071.
10. Taylor KR, Gallo RL,. Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammation. Faseb J 2006; 20: 9-22.
11. Yamagata T, Saito H, Habuchi O, Suzuki S,. Purification and properties of bacterial chondroitinases and chondrosulfatases. J Biol Chem 1968; 243: 1523-1535.
12. Bradbury EJ, Moon LD, Popat RJ, et al,. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 2002; 416: 636-640.
13. Cafferty WB, Bradbury EJ, Lidierth M, et al,. Chondroitinase ABC-mediated plasticity of spinal sensory function. J Neurosci 2008; 28: 11998-12009.
14. Del Rio JA, Soriano E,. Overcoming chondroitin sulphate proteoglycan inhibition of axon growth in the injured brain: lessons from chondroitinase ABC. Curr Pharm Des 2007; 13: 2485-2492.
15. Wang J, Ding J, Jiao H, et al,. Human hypertrophic scar-like nude mouse model: characterization of the molecular and cellular biology of the scar process. Wound Repair Regen 2011; 19: 274-285.
16. Kelly AP,. Update on the management of keloids. Semin Cutan Med Surg 2009; 28: 71-76.
17. Sugahara K, Mikami T,. Chondroitin/dermatan sulfate in the central nervous system. Curr Opin Struct Biol 2007; 17: 536-545.
18. Huang R, Merrilees MJ, Braun K, et al,. Inhibition of versican synthesis by antisense alters smooth muscle cell phenotype and induces elastic fiber formation in vitro and in neointima after vessel injury. Circ Res 2006; 98: 370-377.
19. Yamawaki S, Naitoh M, Ishiko T, Muneuchi G, Suzuki S,. Keloids can be forced into remission with surgical excision and radiation, followed by adjuvant therapy. Ann Plast Surg 2011; 67: 402-406.
20. Kang N, Sivakumar B, Sanders R, Nduka C, Gault D,. Intra-lesional injections of collagenase are ineffective in the treatment of keloid and hypertrophic scars. J Plast Reconstr Aesthet Surg 2006; 59: 693-699.
21. Yagi Y, Muroga E, Naitoh M, et al,. An ex vivo model employing keloid-derived cell-seeded collagen sponges for therapy development. J Invest Dermatol 2013; 133: 386-393.